Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Therapeutic assessment of fractions of Gastrodiae Rhizoma on chronic atrophic gastritis by H NMR-based metabolomics.

< BACK TO ARCHIVE


2020 Feb 25


J Ethnopharmacol


http://www.ncbi.nlm.nih.gov/pubmed/32109546?dopt=Abstract

Therapeutic assessment of fractions of Gastrodiae Rhizoma on chronic atrophic gastritis by H NMR-based metabolomics.

Authors

Therapeutic assessment of fractions of Gastrodiae Rhizoma on chronic atrophic gastritis by H NMR-based metabolomics.
Xu H, Ruan L-Y, Chen C, Fan J-T, Chen J-F, Zhao W-L, Meng H-H, Liu W-Y, Zhao W-L, Zheng Q, Liu Z-C, Wang J-S
J Ethnopharmacol. 2020 Feb 25:112403.
PMID: 32109546.

Abstract

Gastrodiae Rhizoma (GR), a well-known and commonly-used TCM (Traditional Chinese Medicine) for treating headache, dizziness, tetanus, epilepsy, and etc., has been proven to relieve chronic atrophic gastritis (CAG). Due to its complex ingredients, the active fractions responsible for the treatment of CAG remain largely unknown.
Read This Paper